Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • Medical Devices (& Hospital Services) • Life Science |
Investing | United States |
Investment Range | $1,590,000 - $1,700,000 |
Cato BioVentures is the venture capital affiliate of Cato Research. The firm has partnered with entrepreneurs, academic institutions and a broad base of biotech and pharmaceutical companies for successful product development programs. It invests in all stages of development and across multiple therapeutic areas in both private and public companies. It operates as long-term investor who can assist it's portfolio companies with product development including clinical development, regulatory affairs, manufacturing, government, private foundation grant-writing and corporate development which includes corporate finance, strategic planning and corporate partnering. It is headquartered in Durham, North Carolina.